Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.
Colorectal cancer is the third most common cancer in the Western world. Approximately half of patients will develop liver metastases, which is the most common cause of death. The only potentially curative treatment is surgical resection. However, many patients retain a to small future liver remnant (FLR) to allow for resection directly. There are therefore strategies to decrease the tumor with neoadjuvant chemotherapy and to increase the FLR. An accepted strategy to increase the FLR is portal vein occlusion (PVO). A concern with this strategy is that a large proportion of patients will never be operated because of progression during the interval between PVO and resection. ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) is a new procedure with a high resection rate. A concern with this approach is the rather high frequency of complications and high mortality, compared to PVO. In this review, it is shown that with ALPPS the resection rate was 97.1% for CRLM and the mortality rate for all diagnoses was 9.6%. The mortality rate was likely lower for patients with CRLM, but some data were lacking in the reports. Due to the novelty of ALPPS, the indications and technique are not yet established but there are arguments for ALPPS in the context of CRLM and a small FLR.
Kristina Hasselgren, Per Sandström, Bergthor Björnsson, Department of Surgery, County Council of Östergötland, Linköping University, 58185 Linköping, Sweden.
Kristina
K
Hasselgren
Kristina Hasselgren, Per Sandström, Bergthor Björnsson, Department of Surgery, County Council of Östergötland, Linköping University, 58185 Linköping, Sweden.
Per
P
Sandström
Kristina Hasselgren, Per Sandström, Bergthor Björnsson, Department of Surgery, County Council of Östergötland, Linköping University, 58185 Linköping, Sweden.
Bergthor
B
Björnsson
D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000401:mortality / Q000473:pathology*; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D006801:Humans; D008026:Ligation; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D020360:Neoadjuvant Therapy; D018579:Patient Selection; D011169:Portal Vein / Q000601:surgery*; D012307:Risk Factors; D016896:Treatment Outcome
Associating liver partition and portal vein ligation for staged hepatectomy; Colorectal liver metastases; Liver surgery; Neoadjuvant chemotherapy; Portal vein embolization